首页> 外文期刊>Acta biomaterialia >Human embryonic stem cell encapsulation in alginate microbeads in macroporous calcium phosphate cement for bone tissue engineering
【24h】

Human embryonic stem cell encapsulation in alginate microbeads in macroporous calcium phosphate cement for bone tissue engineering

机译:人类胚胎干细胞在大孔磷酸钙水泥中的藻酸盐微珠中包封,用于骨组织工程

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Human embryonic stem cells (hESC) are promising for use in regenerative medicine applications because of their strong proliferative ability and multilineage differentiation capability. To date there have been no reports on hESC seeding with calcium phosphate cement (CPC). The objective of this study was to investigate hESC-derived mesenchymal stem cell (hESCd-MSC) encapsulation in hydrogel microbeads in macroporous CPC for bone tissue engineering. hESC were cultured to form embryoid bodies (EB), and the MSC were then migrated out of the EB. hESCd-MSC had surface markers characteristic of MSC, with positive alkaline phosphatase (ALP) staining when cultured in osteogenic medium. hESCd-MSC were encapsulated in alginate at a density of 1 million cells ml -1, with an average microbead size of 207 μm. CPC contained mannitol porogen to create a porosity of 64% and 218-μm macropores, with 20% absorbable fibers for additional porosity when the fibers degrade. hESCd-MSC encapsulated in microbeads in CPC had good viability from 1 to 21 days. ALP gene expression at 21 days was 25-fold that at 1 day. Osteocalcin (OC) at 21 days was two orders of magnitude of that at 1 day. ALP activity in colorimetric p-nitrophenyl phosphate assay at 21 days was fivefold that at 1 day. Mineral synthesis by the encapsulated hESCd-MSC at 21 days was sevenfold that at 1 day. Potential benefits of the CPC-stem cell paste include injectability, intimate adaptation to complex-shaped bone defects, ease in contouring to achieve esthetics in maxillofacial repairs, and in situ setting ability. In conclusion, hESCd-MSC were encapsulated in alginate microbeads in macroporous CPC, showing good cell viability, osteogenic differentiation and mineral synthesis for the first time. The hESCd-MSC-encapsulating macroporous CPC construct is promising for bone regeneration in a wide range of orthopedic and maxillofacial applications.
机译:人类胚胎干细胞(hESC)具有强大的增殖能力和多系分化能力,因此有望用于再生医学。迄今为止,还没有关于用磷酸钙水泥(CPC)播种hESC的报道。这项研究的目的是研究hESC衍生的间充质干细胞(hESCd-MSC)封装在大孔CPC中的水凝胶微珠中,用于骨组织工程。培养hESC形成胚状体(EB),然后将MSC移出EB。 hESCd-MSC具有MSC的表面标记,当在成骨培养基中培养时具有正碱性磷酸酶(ALP)染色。将hESCd-MSC封装在藻酸盐中,密度为100万个细胞ml -1,平均微珠大小为207μm。 CPC包含甘露醇成孔剂,可形成64%的孔隙度和218-μm大孔,可降解纤维具有20%的可吸收纤维,可在纤维降解时产生额外的孔隙度。封装在CPC中微珠中的hESCd-MSC在1到21天之间具有良好的生存能力。 21天时ALP基因表达是1天时的25倍。第21天的骨钙素(OC)是第1天的两个数量级。比色对硝基苯基磷酸酯测定在21天时的ALP活性是1天时的五倍。封装的hESCd-MSC在21天时的矿物质合成是1天时的七倍。 CPC干细胞糊剂的潜在好处包括可注射性,对复杂形状的骨缺损的紧密适应性,易于勾勒轮廓以实现颌面修复的美学效果以及原位固定能力。总之,将hESCd-MSC封装在大孔CPC中的藻酸盐微珠中,首次显示出良好的细胞活力,成骨分化和矿物质合成。封装hESCd-MSC的大孔CPC构建体有望在各种骨科和颌面应用中实现骨再生。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号